Table 6.

DNA content in each phase of Hepatocytes after treatment with 18α-GL and TGF-β1 (8 ng/ml) (x±s, n=3).

18α-GL (mg/ml)	G0/G1 (%)	S (%)	G2/M (%)
0 (control)	59.9±0.6	33.9±0.7	6.2±0.2
0.1	62.6±1.2	34.5±0.3	2.8±1.0#
1	54.7±1.1**	42.4±1.1*	2.8±1.1##

^*P<0.05 vs. control group;

^*P<0.01,

^#P<0.05,

^##P<0.05 vs. control group.